Department of Radiation Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Deparment of Laboratory Medicine and Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Medicine (Baltimore). 2021 Nov 19;100(46):e27956. doi: 10.1097/MD.0000000000027956.
Locally advanced nasopharyngeal carcinoma (LA-NPC) is more prevalent in some geographic regions, including Saudi Arabia. Typically, Tumor-Node-Metastasis (TNM) staging is used in NPC. However, it is inadequate to assess the prognosis of LA-NPC.Therefore, we analyzed and compared several previously reported prognostic factors in LA-NPC patients, retrospectively, including CD3+tumor-infiltrating lymphocytes (TIL) and peripheral blood hemoglobin, EBV DNA copy number, ratios of albumin-to-alkaline phosphatase ratio (AAPR), neutrophils, or platelets-to-lymphocytes (NLR, PLR). The studied cohort was 83 LA-NPC patients previously recruited for a randomized phase II trial with a different aim.Univariate cox regression analysis showed no significant correlation between any of the tested variables with disease-free survival (DFS) or overall survival (OS) with the exception of low CD3+ TIL infiltration, which correlated significantly with DFS (HR = 6.7, P = <.001) and OS (HR = 9.1, P = .043). Similarly, in a validated multivariate cox regression analysis, only low CD3+ TIL correlated significantly with DFS (HR = 7.0, P < .001 for TIL) and OS (HR = 9.4, P = .040).Among tested parameters, CD3+ TIL was the only independent prognostic marker for DFS and OS in LA-NPC patients treated with CCRT. This study supports the use of CD3+TIL, over other factors, as an independent prognostic factor in LA-NPC.
局部晚期鼻咽癌(LA-NPC)在一些地理区域更为普遍,包括沙特阿拉伯。通常使用肿瘤-淋巴结-转移(TNM)分期来分期 NPC。然而,它不足以评估 LA-NPC 的预后。因此,我们回顾性地分析和比较了之前报道的几种 LA-NPC 患者的预后因素,包括 CD3+肿瘤浸润淋巴细胞(TIL)和外周血血红蛋白、EBV DNA 拷贝数、白蛋白-碱性磷酸酶比值(AAPR)、中性粒细胞或血小板与淋巴细胞比值(NLR、PLR)的比值。该研究队列是之前为一项不同目的的随机 II 期试验招募的 83 例 LA-NPC 患者。单因素 Cox 回归分析显示,除了 CD3+TIL 浸润水平较低与无病生存(DFS)和总生存(OS)显著相关(HR=6.7,P<.001 和 HR=9.1,P=.043)外,所测试的变量与 DFS 或 OS 之间均无显著相关性。同样,在经过验证的多因素 Cox 回归分析中,只有低 CD3+TIL 与 DFS(HR=7.0,P<.001)和 OS(HR=9.4,P=.040)显著相关。在测试的参数中,CD3+TIL 是接受 CCRT 治疗的 LA-NPC 患者 DFS 和 OS 的唯一独立预后标志物。这项研究支持将 CD3+TIL 用作 LA-NPC 的独立预后因素,而不是其他因素。